DALLAS, Jan. 10, 2018 -- Researchers at the University of California, Irvine have found Oleoylethanolamide (OEA), a metabolite naturally found in the human body, to aid in the regulation of appetite, weight and body fat composition. Soon after completing the studies, OEA was submitted and approved for a utility patent for use with the aiding of weight management.
“In our high-calorie consuming society, many adults find it increasingly difficult to manage their weight and body fat,” said Dr. Jay Yepuri, Chief Medical Officer at NutriForward. “RiduZone truly is a weight management supplement unlike others on the market, and we look forward to witnessing the positive impact it will have on the lives of Americans who are working to live healthier lives.”
The patented metabolite, which is naturally found in the small intestine, is a metabolite of dietary oleic acid, helps to regulate hunger by binding to PPAR-Alpha (peroxisome proliferator-activated receptor alpha) receptors, inducing satiety and stimulating lipolysis.
When administered to the body through the natural supplement RiduZone, OEA acts to reduce food intake, appetite and body weight. For optimal weight management, RiduZone should be used in conjunction with a healthy diet and regular exercise.
NutriForward, the maker of RiduZone, has exclusive commercial rights to the utility patent of OEA, making the natural supplement the only FDA-acknowledged OEA supplement on the market.
For more information about OEA and RiduZone, visit www.RiduZone.com. For media inquiries, contact [email protected].
About RiduZone
RiduZone is a patented formulation of OEA designed to support weight loss by helping to reduce calorie consumption and aid in the metabolism of body fat. When consumed, RiduZone releases OEA in the small intestine binds to PPAR-Alpha receptor, which increases the metabolism of body fat and signals to the brain that the user is full. RiduZone retails for $79.99 for a bottle of 60 capsules, and is available for purchase at RiduZone.com.
Media Contact
Valeria Velasco
310-405-0357
[email protected]


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



